How serious ARE the side effects of cabazitaxel?

As has been previously mentioned on this web site, cabazitaxel — a second-generation taxane — has a good chance of being approved some time soon for the treatment of patients with castration-resistant prostate cancer (CRPC) who have already progressed after treatment of docetaxel (Taxotere). However, … READ MORE …

Is RALP potentially associated with fewer complications than open surgery?

A study from the prestigious Karolinska Institute in Sweden has provided some concrete evidence that — with an appropriately high caseload and experience — robot-assisted laparoscopic prostatectomy (RALP) may, in fact, be associated with a significant reduction in surgical complications by comparison with open, radical retropubic prostatecomy (RRP). … READ MORE …

The abstract and the media report don’t quite “synch”

A report published by Reuters within the past couple of hours makes some surprisingly assertive claims about the safety of (unspecified forms of) “radiation therapy” in the treatment of prostate cancer. These claims are all the worse for being based on retrospective analysis as opposed to any sort of prospective clinical trial. … READ MORE …

The Wednesday prostate cancer news: December 10, 2008

There are two news items of significant interest today. One deals with screening behaviors of men living alone; the other with short-term complications following radiotherapy for localized prostate cancer. … READ MORE …

The Saturday prostate cancer post: November 1, 2008

There are a lot of news items this weekend. This first batch addresses studies on:

  • The incidence of clinically insignificant prostate cancer
  • Bladder and rectal cancers as side effects of radiotherapy for management of localized prostate cancer.
  • Fatigue in cancer patients in general (and prostate cancer therapy specifically).
  • The appropriate use of androgen deprivation therapy
  • Second line chemotherapy for castration-resistant prostate cancer. … READ MORE …>